India gets its first Alzheimer’s therapy, will cost nearly a lakh per dose - The Indian Express

India gets its first Alzheimer’s therapy, will cost nearly a lakh per dose    The Indian Express Lilly expands specialty portfolio in India    The Times of India Eli Lilly launches Alzheimer's drug Donanemab in India    Reuters Eli Lilly Launches Alzheimer's Drug Lormalzi Priced At Rs 91,688 Per Vial In India    NDTV Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow    The Economic Times

Original source: Google News